1 Failure to induce remission at 2 weeks |
3 |
1132 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.94 [0.89, 0.98] |
2 Failure to induce remission at 4 weeks |
3 |
1611 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.86, 0.96] |
3 Failure to induce clinical response at 2 weeks |
2 |
1102 |
Risk Ratio (M‐H, Random, 95% CI) |
0.82 [0.66, 1.01] |
4 Failure to induce clinical response at 4 weeks |
3 |
1611 |
Risk Ratio (M‐H, Random, 95% CI) |
0.78 [0.66, 0.92] |
5 Change in CDAI from baseline to 4 weeks |
1 |
507 |
Mean Difference (IV, Fixed, 95% CI) |
‐32.9 [‐47.85, ‐17.95] |
6 Adverse events |
1 |
131 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.75, 1.09] |
7 Withdrawal due to adverse events |
1 |
131 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.46 [0.04, 4.98] |
8 Serious adverse events up to week 12 |
1 |
131 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.93 [0.34, 2.49] |